Mastrapasqua Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.32M | Sell |
39,864
-55
| -0.1% | -$1.95K | 0.16% | 101 |
|
|
2023
Q2 | $1.46M | Buy |
39,919
+1,071
| +3% | +$41.7K | 0.16% | 98 |
|
|
2023
Q1 | $1.59M | Buy |
38,848
+625
| +2% | +$27K | 0.19% | 97 |
|
|
2022
Q4 | $1.96M | Sell |
38,223
-460
| -1% | -$22.1K | 0.26% | 81 |
|
|
2022
Q3 | $1.69M | Buy |
38,683
+3,221
| +9% | +$157K | 0.25% | 84 |
|
|
2022
Q2 | $1.86M | Sell |
35,462
-1,219
| -3% | -$62.1K | 0.25% | 81 |
|
|
2022
Q1 | $1.9M | Sell |
36,681
-4,439
| -11% | -$230K | 0.21% | 89 |
|
|
2021
Q4 | $2.43M | Buy |
41,120
+3,286
| +9% | +$163K | 0.24% | 82 |
|
|
2021
Q3 | $1.63M | Sell |
37,834
-6,267
| -14% | -$278K | 0.18% | 98 |
|
|
2021
Q2 | $1.73M | Buy |
44,101
+6,335
| +17% | +$246K | 0.18% | 96 |
|
|
2021
Q1 | $1.37M | Buy |
37,766
+3,932
| +12% | +$140K | 0.16% | 106 |
|
|
2020
Q4 | $1.25M | Sell |
33,834
-9,047
| -21% | -$332K | 0.16% | 97 |
|
|
2020
Q3 | $1.49M | Buy |
42,881
+9,987
| +30% | +$350K | 0.21% | 90 |
|
|
2020
Q2 | $1.02M | Buy |
32,894
+2,213
| +7% | +$75.2K | 0.16% | 99 |
|
|
2020
Q1 | $950K | Buy |
30,681
+2,229
| +8% | +$76K | 0.18% | 91 |
|
|
2019
Q4 | $1.06M | Sell |
28,452
-179
| -0.6% | -$6.38K | 0.17% | 97 |
|
|
2019
Q3 | $976K | Buy |
28,631
+232
| +0.8% | +$8.44K | 0.18% | 94 |
|
|
2019
Q2 | $1.17M | Buy |
28,399
+2,072
| +8% | +$82.3K | 0.22% | 89 |
|
|
2019
Q1 | $1.06M | Buy |
26,327
+518
| +2% | +$20.7K | 0.2% | 96 |
|
|
2018
Q4 | $1.07M | Sell |
25,809
-454
| -2% | -$18.8K | 0.24% | 91 |
|
|
2018
Q3 | $1.1M | Sell |
26,263
-1,396
| -5% | -$53.7K | 0.21% | 90 |
|
|
2018
Q2 | $952K | Sell |
27,659
-1,486
| -5% | -$50.8K | 0.19% | 95 |
|
|
2018
Q1 | $981K | Buy |
29,145
+52
| +0.2% | +$1.79K | 0.2% | 96 |
|
|
2017
Q4 | $1M | Buy |
29,093
+5,639
| +24% | +$192K | 0.2% | 95 |
|
|
2017
Q3 | $794K | Sell |
23,454
-1,233
| -5% | -$39.6K | 0.16% | 103 |
|
|
2017
Q2 | $787K | Buy |
24,687
+1,745
| +8% | +$55K | 0.17% | 106 |
|
|
2017
Q1 | $745K | Buy |
22,942
+4,566
| +25% | +$144K | 0.17% | 111 |
|
|
2016
Q4 | $566K | Buy |
18,376
+1,331
| +8% | +$40.6K | 0.14% | 110 |
|
|
2016
Q3 | $548K | Sell |
17,045
-264
| -2% | -$8.83K | 0.13% | 110 |
|
|
2016
Q2 | $578K | Buy |
17,309
+633
| +4% | +$20.2K | 0.14% | 105 |
|
|
2016
Q1 | $469K | Buy |
16,676
+537
| +3% | +$15.3K | 0.11% | 115 |
|
|
2015
Q4 | $494K | Sell |
16,139
-748
| -4% | -$23.5K | 0.12% | 108 |
|
|
2015
Q3 | $503K | Buy |
16,887
+785
| +5% | +$25.2K | 0.13% | 107 |
|
|
2015
Q2 | $512K | Buy |
+16,102
| New | +$525K | 0.12% | 103 |
|
|
2015
Q1 | – | Sell |
-15,952
| Closed | -$471K | – | 98 |
|
|
2014
Q4 | $471K | Buy |
+15,952
| New | +$457K | 0.11% | 107 |
|
Other funds holding PFE
Mastrapasqua Asset Management's PFE Position: Q3 2023 in Review
Mastrapasqua Asset Management reduced its Pfizer (PFE) stake by 0.14% in Q3 2023, selling an estimated $1.95K and leaving 39,864 shares worth $1.32M. The position accounts for 0.16% of the portfolio, ranked #101.
Mastrapasqua Asset Management first reported a position in PFE in Q4 2014 and has held it in 35 quarters since. The position peaked at $2.43M in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.
- Mastrapasqua Asset Management held 39,864 shares of Pfizer worth $1.32M as of Q3 2023.
- Mastrapasqua Asset Management sold 55 Pfizer shares in Q3 2023, an estimated $1.95K.
- Pfizer made up 0.16% of Mastrapasqua Asset Management's portfolio in Q3 2023, its #101 holding.
- Mastrapasqua Asset Management first reported a position in Pfizer in Q4 2014 and has held it in 35 quarters since.
- Mastrapasqua Asset Management's Pfizer position peaked at $2.43M in Q4 2021.
- 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.
Based on Mastrapasqua Asset Management's 13F filing for Q3 2023, filed 25 Oct 2023.